Phase I/II open label, multicentre, single arm study assessing neoadjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with bladder cancer.

Trial Profile

Phase I/II open label, multicentre, single arm study assessing neoadjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with bladder cancer.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Cisplatin (Primary) ; Vinflunine (Primary)
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Acronyms JaNEO
  • Most Recent Events

    • 08 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 09 Dec 2016 New trial record
    • 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top